pharmaceutical marketing, health care products, pharmaceutical market research, pharmaceutical marketing research,  pharmaceutical research, pharmaceuticals, pharmaceutical industry, pharmaceutical companies, pharmaceutical company, pharmaceutical product, pharmaceutical, medical marketing, health care product

HOME

PRODUCTS

DISTRIBUTORS

FEEDBACK FORM

M R REPORTING

CONTACT US

Start Cancer Therapy … Start Caphosol® 
Keep oral mucositis away - and keep patients on track with their cancer care

  • OM may lead to cancer treatment interruptions, which may result in poorer outcomes
  • Caphosol® helps maintain the integrity of the oral cavity to treat the underlying cause of OM
  • Caphosol® use is clinically proven to reduce the occurrence and duration of OM and associated pain
  • Many patients can prevent OM altogether with Caphosol®

CAPHOSOL® 1 box contains 4 X 30 doses treatment. 1 dose treatment=2single-dose containers, each 15ml, mixed together.
Pharmaceutical form :
Mouth Rinse. Aqueous solution. Caphosol® is a preparation comprising two separately packaged aqueous solutions, a phosphate solution (Caphosol® A) and a calcium solution (Caphosol® B) which, when both solutions are combined in equal volumes, forms a solution supersaturated with respect to both calcium and phosphate ions.
Actions: Caphosol® is an electrolyte solution designed to moisten, lubricate and clean the oral cavity including the mucosa of the mouth, tongue and oropharynx.
Indications: Caphosol® is indicated for dryness of the mouth and oropharynx (hyposalivation, xerostomia), regardless of the cause and regardless of whether the condition is temporary or permanent. Caphosol® is also indicated as an adjunct to standard oral care in the prevention and treatment of the mucositis that may be caused by radiation or high dose chemotherapy. Relief of dryness of the oral mucosa in these conditions is associated with amelioration of pain.
Directions for use: 
Caphosol® is well tolerated
• No known drug interactions
Caphosol® is easy to use
Simply instruct patients to
• Mix the 2 ampoules together
• Swish with half the solution
• Swish again with the other half
• Spit out
Patients report high satisfaction with Caphosol®
• No unpleasant taste
• Flexible dosing from 4 to 10 times per day depending on the patient's need
Special
Precautions for use: Avoid eating or drinking for at least during 15 minutes after use. Do not use if the seal of the single-dose container is broken or the single-dose container shows sign of leakage or damage. Contains sodium (71mg per 30ml dose treatment). Patients restricted to a low sodium diet should consult their physician before use. Keep out of the reach of children. No adverse effects are anticipated, if Caphosol® is swallowed accidentally. 

  Top

Click Here For More Information
 Copyright © 2005 Paviour Pharmaceuticals Pvt Ltd. All rights reserved. Designed & Developed by Pragya Net Technology.